Predicting cancer drug responses before clinical trials begin

Tech in AsiaAugust 7, 2026en

AlphaGrid uses AI and patient-derived organoids to build digital twins of tumors, testing drug responses before clinical trials even begin.

This is a short summary published by AI Global Wire. The full article is owned and hosted by Tech in Asia — open it there to read it in full.